SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-20-013753
Filing Date
2020-12-18
Accepted
2020-12-18 17:04:49
Documents
7
Period of Report
2020-12-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ndra_8k.htm 8-K 39027
2 UNDERWRITING AGREEMENT, DATED DECEMBER 15, 2020 ndra_ex11.htm EX-1.1 524138
3 OPINION ndra_ex51.htm EX-5.1 13809
4 PRESS RELEASE, DATED DECEMBER 15, 2020 ndra_ex991.htm EX-99.1 14881
5 PRESS RELEASE, DATED DECEMBER 15, 2020 ndra_ex992.htm EX-99.2 15443
6 PRESS RELEASE, DATED DECEMBER 18, 2020 ndra_ex993.htm EX-99.3 11537
7 IMAGE ndra_ex51000.jpg GRAPHIC 2295
  Complete submission text file 0001654954-20-013753.txt   623403
Mailing Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105
Business Address 3600 GREEN COURT SUITE 350 ANN ARBOR MI 48105 734-335-0468
ENDRA Life Sciences Inc. (Filer) CIK: 0001681682 (see all company filings)

IRS No.: 260579295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37969 | Film No.: 201401357
SIC: 3845 Electromedical & Electrotherapeutic Apparatus